-
Omontys-Related Adverse Reactions And Deaths Update: Are There More Cases Than Initially Disclosed
FDA Adverse Event Report For Omontys Reveals Affymax And Takeda May Have Downplayed Magnitude Of Problems (Posted by Tom Lamb at DrugInjuryWatch.com) When the dialysis – anemia medication Omontys was recalled in February 2013 it…
-
The Widespread “Off-Label” Use Of Medtronic Infuse Bone Graft And Associated Reports Of Adverse Events Involving Serious Injury
Up To 85% Of The Times This Infuse Device / System "Hybrid" Product Is Used By Surgeons, It Is For Some Surgery Type Not Approved By The FDA (Posted by Tom Lamb at DrugInjuryWatch.com) An April 2013…
-
Byetta / Januvia / Victoza: Update On Possible Association Between These Newer Diabetes Drugs And Pancreatic Cancer As A Side Effect
Drug Safety Regulatory Developments And The Ongoing Academic Discussions About Provocative 2013 Medical Journal Article By Peter Butler At UCLA (Posted by Tom Lamb at DrugInjuryWatch.com)We last wrote about the possible association between pancreatic…
-
Drug Safety Significance Of Adverse Reactions Reports For Xarelto Blood Thinner Pill Is Uncertain, At Best
Does The Apparently High Number Of Side Effects Cases From Germany Thus Far In 2013 Mean There Is Safety Signal, Or Is This All About Nothing (Posted by Tom Lamb at DrugInjuryWatch.com)On September 8,…
-
Higher Risk Of Venous Thrombosis – Blood Clot Side Effects Like DVT And PE With YAZ / Yasmin Birth Control Pills Is Confirmed By September 2013 BMJ Medical Journal Article
As With So-Called "Third Generation" Oral Contraceptives, For Drospirenone (DRSP) Containing Pills The Risk Is 50% To 80% Higher Than Levonorgestrel Pills (Posted by Tom Lamb at DrugInjuryWatch.com)On September 12, 2013 the well-known BMJ medical journal…
